Assuntos
GTP Fosfo-Hidrolases/genética , Proteínas Associadas aos Microtúbulos/genética , Proteínas Mitocondriais/genética , Mutação/genética , Transtornos Parkinsonianos/genética , Adulto , Dinaminas , Evolução Fatal , Feminino , Humanos , Mitocôndrias/metabolismo , Transtornos Parkinsonianos/metabolismoRESUMO
The general concept of inborn error of metabolism is currently evolving into the interface between classical biochemistry and cellular biology. Basic neuroscience is providing increasing knowledge about the mechanisms of neurotransmission and novel related disorders are being described. There is a necessity of updating the classic concept of "inborn error of neurotransmitters (NT)" that considers mainly defects of synthesis and catabolism and transport of low weight NT molecules. Monogenic defects of the synaptic vesicle (SV), and especially those affecting the SV cycle are a potential new group of NT disorders since they end up in abnormal NT turnover and release. The most common clinical manifestations include epilepsy, intellectual disability, autism and movement disorders, and are in the continuum symptoms of synaptopathies. Interestingly, brain malformations and neurodegenerative conditions are also present within SV diseases. Metabolomics, proteomics, and other -omic techniques probably will provide biomarkers and contribute to therapeutic targets in the future.
Assuntos
Encefalopatias Metabólicas Congênitas/complicações , Anormalidades Congênitas/etiologia , Epilepsia/etiologia , Deficiência Intelectual/etiologia , Transtornos dos Movimentos/etiologia , Doenças Neurodegenerativas/etiologia , Doenças Neuromusculares/etiologia , Transmissão Sináptica/fisiologia , Vesículas Sinápticas/patologia , HumanosRESUMO
Pyruvate carboxylase deficiency is a rare metabolic disorder, with three different phenotypes. We aim to report the case of a newborn presenting the severe neonatal form of this deficiency (the B or "French" phenotype, hypokinesia and rigidity being the main features) and the results of the study of classic neurotransmitters involved in movement control. Hyperdopaminergic transmission (both in the cerebrospinal fluid and in the substantia nigra) and hypoGABAergic transmission (in the substantia nigra) were found. Both gamma-aminobutyric acid and dopamine markers were found coexisting in individual neurons of the substantia nigra. This is the first time this phenomenon has been reported in the literature. We discuss the possible role of GABAergic deficiency, its interaction with other neurotransmitters and its implication in neurotransmitter homeostasis. A better comprehension of that field would increase understanding of the pathophysiology of neurological symptoms and neurotransmitter plasticity.
Assuntos
Transtornos Parkinsonianos/diagnóstico , Doença da Deficiência de Piruvato Carboxilase/diagnóstico , Encéfalo/metabolismo , Encéfalo/patologia , Evolução Fatal , Feminino , Neurônios GABAérgicos/fisiologia , Humanos , Transtornos Parkinsonianos/enzimologia , Transtornos Parkinsonianos/fisiopatologia , Doença da Deficiência de Piruvato Carboxilase/fisiopatologia , Transmissão Sináptica , Tirosina 3-Mono-Oxigenase/metabolismoRESUMO
Sotos syndrome is an overgrowth condition characterized by facial gestalt, macrocephaly, excessive height, and different degrees of developmental delay. We report the case of a 20-month-old boy with a confirmatory molecular study, showing a novel nonsense mutation in NSD1 gene, presenting cutis laxa as the main phenotypic trait in the neonatal period. This association has been previously described in 3 patients with a clinical diagnosis of Sotos syndrome, without confirmatory molecular analysis. Our patient was tested for congenital disorders of glycosilation as part of the cutis laxa differential diagnosis. During the postnatal follow-up period the head circumference and height became greater than 97(th) percentile (having been close to the 50(th) in the newborn period). These facts and the progressive development of characteristic phenotypic features of Sotos syndrome during the first months of life gave us the clue for the clinical diagnosis and the molecular investigation.